Article
Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in atherosclerotic cardiovascular disease phenotypes: a systematic review and meta-analysis.
European heart journal. Cardiovascular pharmacotherapy - 13 Mar 2025
Lin Yu-Min, Wu Jheng-Yan, Lee Mei-Chuan, Su Chen-Lun, Toh Han Siong, Chang Wei-Ting, Chen Sih-Yao, Kuo Fang-Hsiu, Tang Hsin-Ju, Liao Chia-Te
Abstract excerpt
BACKGROUND: Atherosclerotic cardiovascular disease (ASCVD) encompasses various phenotypes with elevated risks of major adverse cardiovascular events (MACEs). This study aimed to assess the comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) across diverse ASCVD phenotypes. METHODS AND RESULTS: We conducted a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.